A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant

JAMA. 2023 Jul 3;330(1):27-29. doi: 10.1001/jama.2023.9100.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiviral Agents* / therapeutic use
  • Cytomegalovirus Infections* / etiology
  • Cytomegalovirus Infections* / prevention & control
  • Ganciclovir / therapeutic use
  • Humans
  • Kidney Transplantation* / adverse effects
  • Valganciclovir / therapeutic use

Substances

  • Antiviral Agents
  • Ganciclovir
  • Valganciclovir